Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Cash from Investing Activities: 2017-2024

Historic Cash from Investing Activities for IDEAYA Biosciences (IDYA) over the last 8 years, with Dec 2024 value amounting to -$502.6 million.

  • IDEAYA Biosciences' Cash from Investing Activities rose 308.46% to $41.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$29.6 million, marking a year-over-year increase of 92.91%. This contributed to the annual value of -$502.6 million for FY2024, which is 217.16% down from last year.
  • According to the latest figures from FY2024, IDEAYA Biosciences' Cash from Investing Activities is -$502.6 million, which was down 217.16% from -$158.5 million recorded in FY2023.
  • IDEAYA Biosciences' 5-year Cash from Investing Activities high stood at -$33.4 million for FY2022, and its period low was -$502.6 million during FY2024.
  • Its 3-year average for Cash from Investing Activities is -$231.5 million, with a median of -$158.5 million in 2023.
  • Per our database at Business Quant, IDEAYA Biosciences' Cash from Investing Activities plummeted by 6,556.64% in 2020 and then skyrocketed by 52.36% in 2021.
  • Over the past 5 years, IDEAYA Biosciences' Cash from Investing Activities (Yearly) stood at -$146.2 million in 2020, then skyrocketed by 52.36% to -$69.7 million in 2021, then surged by 52.05% to -$33.4 million in 2022, then slumped by 374.36% to -$158.5 million in 2023, then tumbled by 217.16% to -$502.6 million in 2024.